Asian American and Pacific Islander Patients Face Increased Odds of Melanoma Treatment Delay
Source: Dermatology Times, May 2024
Researchers say addressing socioeconomic differences may be the key to addressing this disparity.
A 2020 study published in the Journal of the American Academy of Dermatology1 found that while Asian American and Pacific Islander (AAPI) patients have a significantly lower risk of melanoma than White patients, they face poorer outcomes and an overall lowered risk of survival.
In 2023, researchers Fane et al authors a study titled, “Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: A cross-sectional study." The study, published in the Journal of the European Academy of Dermatology and Venereology, found that AAPI patients also face increased odds of treatment delay when it comes to melanoma.2